RI
PBYI icon

Redwood Investments’s Puma Biotechnology PBYI Stock Holding History

Redwood Investments’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-311,268
Closed -$14.3M – 140
2018
Q3 		$14.3M Sell
311,268
-37,992
-11% -$1.83M 1.11% 34
2018
Q2 		$20.7M Buy
349,260
+154,487
+79% +$8.95M 1.43% 16
2018
Q1 		$13.3M Buy
194,773
+15,178
+8% +$1.14M 0.95% 50
2017
Q4 		$17.8M Buy
179,595
+112,653
+168% +$12.6M 1.25% 29
2017
Q3 		$8.02M Buy
+66,942
New +$6.23M 0.91% 47

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Redwood Investments's PBYI Position: Q4 2018 in Review

Redwood Investments sold out of Puma Biotechnology (PBYI) in Q4 2018, closing a stake of 311,268 shares — an estimated $14.3M sold.

Redwood Investments first reported a position in PBYI in Q3 2017 and held it in 5 quarters. The position peaked at $20.7M in Q2 2018. 141 funds tracked by Wall St. Rank hold PBYI as of Q4 2018.

  • Redwood Investments reported no remaining Puma Biotechnology position as of Q4 2018 after selling out during the quarter.
  • Redwood Investments sold 311,268 Puma Biotechnology shares in Q4 2018, an estimated $14.3M.
  • Redwood Investments first reported a position in Puma Biotechnology in Q3 2017 and held it in 5 quarters.
  • Redwood Investments's Puma Biotechnology position peaked at $20.7M in Q2 2018.
  • 141 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2018.

Based on Redwood Investments's 13F filing for Q4 2018, filed 13 Feb 2019.